{"as_of":"2026-08-08T12:50:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:307da45a4d345208b736a226edc350e98b92c29a9386f90ddf135fa372418711","coverage":[{"denominator":300,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":100,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-06T20:14:36.484419Z","state":"measured"},{"denominator":100,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":100,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-08T06:32:00.761636+00:00","state":"measured"},{"denominator":0,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":0,"source":"paper_references, paper_reference_links","source_observed_at":null,"state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"cited_works","source_observed_at":null,"state":"measured"}],"external_citation_measurements":[],"inbound":[],"links":{"evidence":"/evidence","html":"/paper/2507.03407/citation-record","integrity":"/paper/2507.03407/integrity","json":"/paper/2507.03407/citation-record.json","paper":"/paper/2507.03407"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.465974Z","title":"Nature Reviews Drug Discovery, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":1,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.465974Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:54f60ff3f3deb9da4329647767bc5ec73a3f2d4da1f7d2435e03865969d68830","observation_id":"1ad8d444-0b93-4370-b2ec-9c16e27e1e8f","resolution":{"observed_at":"2026-08-06T20:14:35.465974Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.515634Z","title":"Molecular Therapy Nucleic Acids, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":2,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.515634Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:0e6f3b649f93cb9ca5437a7a1b4ae76673371de04cf86dd04df8a384ad16a0a7","observation_id":"114ccddb-e6e4-412f-9ef2-dc9b92a1280a","resolution":{"observed_at":"2026-08-06T20:14:35.515634Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.586796Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":3,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.586796Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:c5c989b42774a65d7fef005f0cc9c39ec00fbdb50fe85d84b5afa2ac999f2762","observation_id":"8f2b8b1a-5405-494d-a5e3-78a5d36bec55","resolution":{"observed_at":"2026-08-06T20:14:35.586796Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.664584Z","title":"Briefings in Bioinformatics, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":4,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.664584Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:ef6a89b465025c3f6c7edfff892a5a7906dd5f73f0f00c47593510f1115dfdd7","observation_id":"f4c78146-14db-4c06-9e22-efd41dd41784","resolution":{"observed_at":"2026-08-06T20:14:35.664584Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.720266Z","title":"Pharmaceuticals, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":5,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.720266Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:44e510e2ce6cdddb02b8b4b46cbfa58b217d5b754b9f72206ffd5c3e6167ef36","observation_id":"7bd1b908-30f3-4d97-8c60-88f369776624","resolution":{"observed_at":"2026-08-06T20:14:35.720266Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.786669Z","title":"Expert Opinion on Drug Discovery, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":6,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.786669Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:a35040d343da0d0be982d511b4885f8e3810766d8e2e6ff560fb5de46383c021","observation_id":"6e1b797c-fbb1-421e-b634-08c7451d6909","resolution":{"observed_at":"2026-08-06T20:14:35.786669Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.861302Z","title":"European Journal of Pharmaceutical Sciences, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":7,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.861302Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:ec2ed09f30b0338b33fb4458b062c178a7711cdee8c64900af7177786ebb9e5e","observation_id":"dad5ae6e-f7e7-484a-a828-65c9ebbe76a9","resolution":{"observed_at":"2026-08-06T20:14:35.861302Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.930971Z","title":"Artificial Intelligence Review, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":8,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.930971Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:55b418400db036bf8bb86f039471168186f9e6c056a99a23ec0834cd19afd128","observation_id":"ddc50ccb-5dec-4021-857a-a9c3dafa3f26","resolution":{"observed_at":"2026-08-06T20:14:35.930971Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.938957Z","title":"Jama Psychiatry, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":9,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.938957Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:f69565b9b4b6d987e51eefc22efb6f01a3c453787450c732d448af3d7b59f7e6","observation_id":"ab12c733-0872-4e9e-9632-24752fe8b1f3","resolution":{"observed_at":"2026-08-06T20:14:35.938957Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.059671Z","title":"Pharmaceutics, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":10,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.059671Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:d5a16866b0f314b8b058a44d4b18f0c4d8123827fe3c64630b7c8ecb9b0d8d94","observation_id":"a8bd6c04-8fee-4c93-9daa-eae8cb52d86f","resolution":{"observed_at":"2026-08-06T20:14:36.059671Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.156905Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":11,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.156905Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:e6e5c20ec77d58dee25c06662b78ef7347bb912788e91c425b5bf87efabbb63e","observation_id":"9079e92a-8417-4f52-8626-c0fadfeddec4","resolution":{"observed_at":"2026-08-06T20:14:36.156905Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.177421Z","title":"Computational and Structural Biotechnology Journal, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":12,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.177421Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:9ace1e2ea007271904f7236564cc93e38aab2572d9a9dcbef32ecf813bde5930","observation_id":"8198b0f1-1503-4eba-a9b0-3d30e6c29ab1","resolution":{"observed_at":"2026-08-06T20:14:36.177421Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.182125Z","title":"International Journal of Molecular Sciences, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":13,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.182125Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:6d0318ea08189c5bb63daa78490c2479e63388f65d1a1c661e8b1bd03a781859","observation_id":"1bc03f8c-2011-43f7-a05c-6f9ba78589c2","resolution":{"observed_at":"2026-08-06T20:14:36.182125Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.185727Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":14,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.185727Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:24653997660c1fff4f21f200aee89814bda0d34e193a443da5419a6d88f97d23","observation_id":"80a93a8c-4672-4c62-beec-dad70e5f9da7","resolution":{"observed_at":"2026-08-06T20:14:36.185727Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.190158Z","title":"Medicinal Research Reviews, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":15,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.190158Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:3b68d5c8ac17d7d8459e60ccbd496e66b56c4b2a9216253d15a561fbb3c48131","observation_id":"512c6d2f-6018-4546-8e48-3e35ea363e0b","resolution":{"observed_at":"2026-08-06T20:14:36.190158Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.193994Z","title":"Artificial Intelligence Review, 2022","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":16,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.193994Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:a16cb5b6f04a726ee969651f236d89aba23109f6cbea39fbf51fce7daa0b2fa0","observation_id":"fb84ec2a-ac9a-4f7e-ba80-74756457937e","resolution":{"observed_at":"2026-08-06T20:14:36.193994Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.197938Z","title":null,"venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":17,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.197938Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:2e33299789c2fb685892fea5872b0963cb18d9309a12fd9202f7237e9c5867b9","observation_id":"0f888cf1-d890-4a38-85b2-b8df686cccb0","resolution":{"observed_at":"2026-08-06T20:14:36.197938Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.202012Z","title":"Nature Reviews Drug Discovery, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":18,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.202012Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:8ed28fb3cf32c7dc76c577254ca2e78f0b90b0198f5164bff2a0399a8db60cf2","observation_id":"fdc1ffde-fbf3-4937-86e0-fcba1027a234","resolution":{"observed_at":"2026-08-06T20:14:36.202012Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.205374Z","title":"20(2): p","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":19,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.205374Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:5c0189ac0c2f500e8793792606134c42dcfe1e70c5a4b05338c88092dd095cb0","observation_id":"cadc2525-d759-4d52-84c7-1cc9f084ce1d","resolution":{"observed_at":"2026-08-06T20:14:36.205374Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.208903Z","title":"Insel, Editor","venue":null,"work_id":null,"year":2020},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":20,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.208903Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:2e25b82f9875ed9b8addf337749f8edf158570f78b5edc0b8b4e3d94e909ac43","observation_id":"4979eeab-69ec-4519-9b09-9b295e30d2ac","resolution":{"observed_at":"2026-08-06T20:14:36.208903Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.212365Z","title":null,"venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":21,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.212365Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:6f04fcb6d632dd1b70b7332d22d4a70a19a6c976641aa697b2297abd5323a207","observation_id":"d7fc43a7-ea86-454c-98b1-925ee38111fa","resolution":{"observed_at":"2026-08-06T20:14:36.212365Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.216724Z","title":"Grisoni, and G","venue":null,"work_id":null,"year":2020},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":22,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.216724Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:55fb60daaf92d91e1d49d0038cf9bd43bcaabb21089acbba02f287a8ab20f6fd","observation_id":"c8164146-ea4d-4581-8190-0e3a3419211e","resolution":{"observed_at":"2026-08-06T20:14:36.216724Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.221642Z","title":"Expert Opinion on Drug Discovery, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":23,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.221642Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:a2c6d6592ab09d74b91e2ce06e0a18e16dc23311f3867c9cb010d8ee27f99c4a","observation_id":"b518cb0b-82fb-4b07-9ad3-5b47cbf5d9b9","resolution":{"observed_at":"2026-08-06T20:14:36.221642Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.225280Z","title":"Pharmaceuticals, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":24,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.225280Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:948e5963a91c6152ef7094665abb9b710cda66d71ec4bfb4c5772665b80ac41c","observation_id":"a0dc7c3b-bc43-4787-92bb-7a416a79e2b3","resolution":{"observed_at":"2026-08-06T20:14:36.225280Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.229031Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":25,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.229031Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:3c911e7a6f05e7583c35210a8957f0c3fccb591cbbafdcf4fc7cc8ff74fe4d2e","observation_id":"0e6d80f9-2a7d-47d9-b109-1457f93dbcdb","resolution":{"observed_at":"2026-08-06T20:14:36.229031Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.232908Z","title":"Scientific Reports, 2025","venue":null,"work_id":null,"year":1990},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":26,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.232908Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:f74420ce4d06d40e93b250ae3108cbbf2822bacc90a3fb75fc6a24bda9d62a27","observation_id":"93eb8ec4-c327-40f3-b98c-b086aea9829f","resolution":{"observed_at":"2026-08-06T20:14:36.232908Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.236872Z","title":"Scientific Reports, 2024","venue":null,"work_id":null,"year":1990},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":27,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.236872Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:84c6d547cef03c50fc48c595098d1ef7d4a22f8fb1672ed4e56e974a12413945","observation_id":"b985011b-5f9b-4478-a68b-ee13eafcdb19","resolution":{"observed_at":"2026-08-06T20:14:36.236872Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.240344Z","title":"Frontiers in Medicine, 2025","venue":null,"work_id":null,"year":1990},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":28,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.240344Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:a521d6b118cd969df93f3c772ea5329cdca9cef15acd33119916f678b1176cb3","observation_id":"4e837670-95a9-4626-8a96-384fae2b3cf9","resolution":{"observed_at":"2026-08-06T20:14:36.240344Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.243876Z","title":"European Journal of Clinical Investigation, 37","venue":null,"work_id":null,"year":1990},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":29,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.243876Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:7adf290a104c73cb56614aa55d5d0af70a765d4b1e4c7bb35c2643e5ff7018ae","observation_id":"c5d8546d-b201-4f86-ac9f-23c81904f026","resolution":{"observed_at":"2026-08-06T20:14:36.243876Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.247386Z","title":"Nature chemical biology, 2013","venue":null,"work_id":null,"year":2013},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":30,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.247386Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:73e6a475d4fe24cf353f395f1f5ca46746f0884531db84d72b327ee3ae3319e1","observation_id":"82a7f244-1fb9-4af5-ba89-ca13829727a2","resolution":{"observed_at":"2026-08-06T20:14:36.247386Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.251284Z","title":null,"venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":31,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.251284Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:be1e7846a39a0939c494a0a0e36ba161364e5522b6e2ea02774b5fa6d80c1b8d","observation_id":"868f470c-84f1-48be-9e4a-8124a596cc39","resolution":{"observed_at":"2026-08-06T20:14:36.251284Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.254901Z","title":"Nature reviews Drug discovery, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":32,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.254901Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:6748b0fc206cd105268aed15f6b1595d0b94157ca4165fb20ce9a693bf765a08","observation_id":"2d0107cb-8015-4713-a46d-3e3904973264","resolution":{"observed_at":"2026-08-06T20:14:36.254901Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.259042Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":33,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.259042Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:8fb09db555fb3200c2418c936cfdfb51dc97b0177fb0703f9525b04b4f2c1db8","observation_id":"9fe4f64c-219f-46e7-9738-9d8562840e93","resolution":{"observed_at":"2026-08-06T20:14:36.259042Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.262941Z","title":"Data Science and Management, 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":34,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.262941Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:67b5f7b6da3a8a0e50ce2c8e3f947927758a82a08b28e9c2003bd348ab0f512d","observation_id":"161c4855-4e6e-41f3-a97b-0e7150975160","resolution":{"observed_at":"2026-08-06T20:14:36.262941Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.267077Z","title":"Briefings in Bioinformatics, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":35,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.267077Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:f915b6857ad707fbe5a775bef21882a10e7c9c59d059b0e740b1f084e3d1ccab","observation_id":"550397b9-9c91-4369-a332-b8cc89dc8fb9","resolution":{"observed_at":"2026-08-06T20:14:36.267077Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.270375Z","title":null,"venue":null,"work_id":null,"year":2014},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":36,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.270375Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:2ccebfdf8294190f71a9b632eb26a90564f074aeca9cb62cf61caceffa91bda8","observation_id":"75fe2565-d42b-4475-ba62-685665a30f8f","resolution":{"observed_at":"2026-08-06T20:14:36.270375Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.273563Z","title":"Database, 2016","venue":null,"work_id":null,"year":2016},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":37,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.273563Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:74cdb5ed39c35eafec3fca139c9902522e6c088028b89af0792fd8daa6b781d4","observation_id":"410f50d3-66b7-4fdf-aae9-39d5c47ffe72","resolution":{"observed_at":"2026-08-06T20:14:36.273563Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.276706Z","title":"Nucleic acids research, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":38,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.276706Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:765c237bb29db7b7796a007605e988149e18fcfa9c203d2f86f6be1249ca2342","observation_id":"013b9128-cb1c-4033-bc6c-47a3e3b6028b","resolution":{"observed_at":"2026-08-06T20:14:36.276706Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2501.16255","last_updated":"2025-01-27T17:55:37Z","snapshot_observed_at":"2026-07-06T20:26:50.822135Z","submitted_at":"2025-01-27T17:55:37Z","title":"A foundation model for human-AI collaboration in medical literature mining","version":1},"cited_work":{"arxiv_id":"2501.16255","doi":null,"metadata_source":"pith","pith_arxiv_id":"2501.16255","snapshot_observed_at":"2026-08-06T20:14:37.202458Z","title":"A foundation model for human-AI collaboration in medical literature mining","venue":"cs.CL","work_id":"286b6b3e-539a-4245-bd43-733787c17140","year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":39,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.279769Z"},"links":{"cited_paper":"/paper/2501.16255","citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:ad2205066e945909f7d536faf44710b4cf2386eb5ace03025cdcd0859457cec2","observation_id":"ce21d88c-3a36-4214-b589-ef0eb0588ed4","resolution":{"observed_at":"2026-08-06T20:14:37.206079Z","resolver_source":"local_arxiv","status":"metadata_mismatch"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-08T06:32:00.761636+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-08T06:32:00.761636+00:00","source":"crossref"},{"observed_at":"2026-08-08T06:31:55.24221+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.284108Z","title":"European Journal of Technology, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":40,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.284108Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:9c03c57e70c061d1a97d5a40e959cc5e546e6a9cbfad4fcbb024399277e55878","observation_id":"3ebe714b-486a-4de5-b201-eed4e12ffa68","resolution":{"observed_at":"2026-08-06T20:14:36.284108Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.287735Z","title":"BMC bioinformatics, 2022","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":41,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.287735Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:623ab349b2544f929f1c8818830bc29e8b197ddbb19a1f3a5da028746f072bdb","observation_id":"3a4e6adc-bc59-4a67-87ad-aa5942fd1100","resolution":{"observed_at":"2026-08-06T20:14:36.287735Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.291530Z","title":"Nature communications,","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":42,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.291530Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:0b9743ad4dfc142cdbfad4bc5ec5d6c194f98f7e6447e670352320f2f62a168b","observation_id":"60b84165-be5e-475e-ad47-c7d4060c0cf3","resolution":{"observed_at":"2026-08-06T20:14:36.291530Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.294841Z","title":"PeerJ, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":43,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.294841Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:7a72255ec9372fabeacafeb1da0a4077e82cb56b37ed038e403fcba803797caa","observation_id":"575624f5-6e0b-4331-8809-d25f1fefc4ab","resolution":{"observed_at":"2026-08-06T20:14:36.294841Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.297931Z","title":"Frontiers in Artificial Intelligence, 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":44,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.297931Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:aa947f2093bea1fb83f612f3938caf1a7f8355b816aa9e7fce87d53f4a3debe8","observation_id":"578bed97-13d0-4e9c-97af-dae93a82135d","resolution":{"observed_at":"2026-08-06T20:14:36.297931Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.300973Z","title":"Frontiers in pharmacology, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":45,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.300973Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:71fcf274aa7d8151baccf47e500829826af5af5662d6c9f3dc1da2e7b5c9bd84","observation_id":"20acabe7-3411-4f60-a2da-9f01455084d8","resolution":{"observed_at":"2026-08-06T20:14:36.300973Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.304402Z","title":"Scientific reports, 2020","venue":null,"work_id":null,"year":2020},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":46,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.304402Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:7458c3690d319e588f20ca2323131dba3618b8688f9e76293c0a1fd379c02fde","observation_id":"8c704e7c-816d-4f47-a7e2-d08338cb763c","resolution":{"observed_at":"2026-08-06T20:14:36.304402Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.307524Z","title":"Nature Biotechnology, 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":47,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.307524Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:f06d3e3996f84baaa1dcbf0377b14fa11f3a91c161c886b46ef4fed4267f6ca9","observation_id":"d453bb6a-4476-4982-9dfd-e798ecd70888","resolution":{"observed_at":"2026-08-06T20:14:36.307524Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.310690Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":48,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.310690Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:150a53ab038902e32cb9cba0fdf12b20a01110d3a0d0e57aac4176e4ff6ab676","observation_id":"9f3de34a-a1b9-4a51-bf57-814fa3223b47","resolution":{"observed_at":"2026-08-06T20:14:36.310690Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.313867Z","title":"Gene \\& Protein in Disease, 2022","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":49,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.313867Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:12569863a6161e0958b8a7d032b3d7f1c047ad19937c63256d1b810e06608df7","observation_id":"db230fd8-2a22-486f-83f1-2d43d3aa3ca0","resolution":{"observed_at":"2026-08-06T20:14:36.313867Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.317098Z","title":"Suratanee, and K","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":50,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.317098Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:350377fde56fab18c3023f7a7b1fd7bb42616e6507539c375e48ea998afc817e","observation_id":"6a67e185-df89-450f-afef-c1e3ee1f5162","resolution":{"observed_at":"2026-08-06T20:14:36.317098Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.320365Z","title":"Ghosh, and V","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":51,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.320365Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:f19b57415e8ab350636981b9b96f46e5841ca9d6d51b6e53203e44b88176232f","observation_id":"aa5450bd-dad6-4af4-b7f0-3137741043d5","resolution":{"observed_at":"2026-08-06T20:14:36.320365Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.323573Z","title":"Gulbahce, and J","venue":null,"work_id":null,"year":2011},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":52,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.323573Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:ca5d36017b910de923d6ace2047ed8c49fa0cc38ab4e07ccb4be06aafe1d5c81","observation_id":"71b87c24-5a9d-49fb-8759-10b83ed084d7","resolution":{"observed_at":"2026-08-06T20:14:36.323573Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.326927Z","title":null,"venue":null,"work_id":null,"year":2012},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":53,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.326927Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:c762f6fbbd2a603ba260810259a2c5b054b5dec2216d9e6906a499c911f725ba","observation_id":"670a0f13-d76d-4894-b67f-1136c2677b4c","resolution":{"observed_at":"2026-08-06T20:14:36.326927Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.330950Z","title":"IEEE Access, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":54,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.330950Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:75bcc4dd04bc21ae18ed1b3c07ef05c05e2e8ad7b4451f794017aa5027a21d36","observation_id":"2de9fcc9-022f-4286-a62e-3be24ceaeb19","resolution":{"observed_at":"2026-08-06T20:14:36.330950Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.334616Z","title":"Bioinformatics, 2019","venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":55,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.334616Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:73536de08da858cf9c48bc194350ae46ab9be8dc80ada3f1f3da697ad47a55dc","observation_id":"a16b966b-4c59-442e-bd61-80f5faa530c1","resolution":{"observed_at":"2026-08-06T20:14:36.334616Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.337787Z","title":"Briefings in bioinformatics, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":56,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.337787Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:e82cb4a474e447ddd273148b7d7b75daadff71bdf2793165d15791cbadc72891","observation_id":"49507e3f-9a42-4ada-91c5-e153b4d38495","resolution":{"observed_at":"2026-08-06T20:14:36.337787Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.341008Z","title":"Chemical Science, 2020","venue":null,"work_id":null,"year":2020},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":57,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.341008Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:2fa45cbefbd2e8332805e04cf5fdeb53b7f164bf62418a7ad98589065723a145","observation_id":"c5a45d2f-d6d2-4890-9587-bdd6b4321605","resolution":{"observed_at":"2026-08-06T20:14:36.341008Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.344535Z","title":"Thafar, and M","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":58,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.344535Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:ad5c128a724151974079152d53e5fce7604871c776410e12f6071617b39e41ba","observation_id":"1aece128-ed38-4ba2-8198-84a1ac021d31","resolution":{"observed_at":"2026-08-06T20:14:36.344535Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.347996Z","title":"International Journal of Quantum Chemistry, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":59,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.347996Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:757e54854692598ad370eff719b25a3bdb1a8718e46616de59ecd64a60ea055d","observation_id":"261a50da-6aea-45de-90fc-73b46feaaca0","resolution":{"observed_at":"2026-08-06T20:14:36.347996Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.351292Z","title":"Nature Machine Intelligence, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":60,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.351292Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:6e43bfb74d198ad274f671991fa9e2d7373e6294d777b8bb5fce0d3e835f4706","observation_id":"794a9378-f72d-4e58-b3fb-0341a5208061","resolution":{"observed_at":"2026-08-06T20:14:36.351292Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.354750Z","title":"Nature communications, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":61,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.354750Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:97118dd92f4e0b59a5d58454c29572c2cd7fd971844aa006779a8647b3f67092","observation_id":"268db3f6-a8a8-4f17-a7ce-ecba8db8fe16","resolution":{"observed_at":"2026-08-06T20:14:36.354750Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.358387Z","title":null,"venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":62,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.358387Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:cc266c4394c1663b6f40068c7b9ea5e02c8624ad52da158374fff575b3a46e27","observation_id":"97521237-4797-4621-8ca6-c35a73529e5e","resolution":{"observed_at":"2026-08-06T20:14:36.358387Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.361755Z","title":"Nature reviews Drug discovery, 2003","venue":null,"work_id":null,"year":2003},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":63,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.361755Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:24c31e9573987fe46e29dfd23f68358a376c101b65be9c372d223096490d1069","observation_id":"c915eadb-95d1-4d46-9ac7-04ada7ca9101","resolution":{"observed_at":"2026-08-06T20:14:36.361755Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.365647Z","title":"Combinatorial chemistry \\& high throughput screening, 2003","venue":null,"work_id":null,"year":2003},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":64,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.365647Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:bb6f98df52ae0a24d0d4f0d05b179971dd5c60121530886e13ef2f80d32377fd","observation_id":"497a1138-2837-4438-b757-b186413f3372","resolution":{"observed_at":"2026-08-06T20:14:36.365647Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.369296Z","title":"Onwuli, and A","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":65,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.369296Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:033b7c4ef876ac04173cc2de65afd6d680c0edb3c6d895c7c50bf19b6636c602","observation_id":"b0a06dd3-85fd-4fb0-b199-6e81fb2b731c","resolution":{"observed_at":"2026-08-06T20:14:36.369296Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.373348Z","title":"npj Drug Discovery, 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":66,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.373348Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:d36ea78ac3f8ef405dcce05e5f947be9afcf8953250d313c973f9f93cf2705e4","observation_id":"1fa4202c-8eaf-4477-b943-b7b8cfb318d3","resolution":{"observed_at":"2026-08-06T20:14:36.373348Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.376597Z","title":"Trends in Chemistry, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":67,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.376597Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:da5b706d3fc2bcf1adfcf4404af5d5d41423db231746ed577a5e696a82ac42d5","observation_id":"24b4c54f-7aff-482b-b597-2622d6f18227","resolution":{"observed_at":"2026-08-06T20:14:36.376597Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.379778Z","title":"Current opinion in chemical biology, 2007","venue":null,"work_id":null,"year":2007},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":68,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.379778Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:dd024084508c0e099f3e2e4239318e937043b12daf66cb9226438d47bf20cddc","observation_id":"bfc7053d-f929-45cb-8a09-334ef978246d","resolution":{"observed_at":"2026-08-06T20:14:36.379778Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.382728Z","title":"Journal of chemical information and modeling, 2012","venue":null,"work_id":null,"year":2012},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":69,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.382728Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:f8eb73ccbc1fe3fea646c8b51ab8349ac43a47dc935749f7247120e54f0c2e76","observation_id":"1a9cc169-92cf-4db7-ab3b-56b73a4c4e7e","resolution":{"observed_at":"2026-08-06T20:14:36.382728Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.385871Z","title":"Journal of medicinal chemistry, 2010","venue":null,"work_id":null,"year":2010},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":70,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.385871Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:da0827df70b6abaf56edb0abd79f8a533ea6b873709679389dbb4c090dd098cc","observation_id":"c120821d-909c-484b-940b-d2ec3e51a361","resolution":{"observed_at":"2026-08-06T20:14:36.385871Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.388946Z","title":"European Journal of Medicinal Chemistry, 2024: p","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":71,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.388946Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:27487bcf207137b00ac74d596a996ad711def8386999e79e7935892ca7b29e47","observation_id":"dc31b134-5bce-4c64-8f6f-6e2d5da0f10a","resolution":{"observed_at":"2026-08-06T20:14:36.388946Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.392211Z","title":"Nature Communications, 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":72,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.392211Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:cbf030c5b496b94013f1478a3223f782be97c08cb88243e248bbb2164b9a1016","observation_id":"fdf1518b-f1e5-4116-b3b1-2a21387e9df4","resolution":{"observed_at":"2026-08-06T20:14:36.392211Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.395465Z","title":"Nature Communications, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":73,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.395465Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:74ffda6028ecddad8f4226c47487ed11b7b2bbc181a6cd86fd21b9afbde36568","observation_id":"f6aa335f-3d4d-4936-b090-40cd00fa937c","resolution":{"observed_at":"2026-08-06T20:14:36.395465Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.398787Z","title":"Signal Transduction and Targeted Therapy, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":74,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.398787Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:3804f8d7c61b99277a71faa0c3530c35897ae20695356c8c5e0f01d2671bcacc","observation_id":"4641c422-d092-44ae-9608-35ffd573e132","resolution":{"observed_at":"2026-08-06T20:14:36.398787Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.402713Z","title":"Beni -Suef University Journal of Basic and Applied Sciences, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":75,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.402713Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:e7d602219e1e15ca4e35d3767c21aae6534448c73f070d7a38e8576d2c2ccc07","observation_id":"ac207edf-edf4-481e-8fc3-92fa94264e5f","resolution":{"observed_at":"2026-08-06T20:14:36.402713Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.406183Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":76,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.406183Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:5fd1ef980f73da4e35621f503a44cc16be8f049c1cacc78c9497a8fa2fa166f7","observation_id":"93f3d750-be24-4fb6-8fed-f84fc2656991","resolution":{"observed_at":"2026-08-06T20:14:36.406183Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.409157Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":77,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.409157Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:b2f42143ebb36261a05cd6462c4b0ca3feea9bf68cd46ec6b2b25cb6e1de4064","observation_id":"f0d2dcc3-26c1-4c23-bea5-876d5ed8b56e","resolution":{"observed_at":"2026-08-06T20:14:36.409157Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.412110Z","title":"Briefings in Bioinformatics, 2022","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":78,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.412110Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:538b1d26cf520da806eb5cfbb930653471d3bb03c0b88c772410b8547cbbecc5","observation_id":"ae22081f-37d3-4345-84de-08b0ba2524a0","resolution":{"observed_at":"2026-08-06T20:14:36.412110Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.414810Z","title":null,"venue":null,"work_id":null,"year":2010},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":79,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.414810Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:a17b17e3dbd7f8a4cf15ba9e1ae63d2f1d1f12abf08bd08705cf13907234f8da","observation_id":"d0299c87-03a8-450a-bd44-e99385c9a656","resolution":{"observed_at":"2026-08-06T20:14:36.414810Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.417690Z","title":"BMC bioinformatics, 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":80,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.417690Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:f6341b9e721685fd48f68e76e6e45d81f08196aba3ada6cd123e260669e073f0","observation_id":"21db8aa0-338f-4f36-b890-05223e89cd2b","resolution":{"observed_at":"2026-08-06T20:14:36.417690Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.420648Z","title":"Communications Chemistry,","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":81,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.420648Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:6c3cb658d5c672337efb9c9688aa8070dd7116e50668f2d9e98a6eb314781e17","observation_id":"57cbb3e7-205d-4412-b379-5e303a40457d","resolution":{"observed_at":"2026-08-06T20:14:36.420648Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.424791Z","title":"Morris, and P.C","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":82,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.424791Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:bb7c5695454cc24ff8e1cfe285a8dcd72a442ac5ddc12f1c7f780f2df4d5ae35","observation_id":"9ce2d5b5-c0ba-4756-a1d3-df0a024ccea5","resolution":{"observed_at":"2026-08-06T20:14:36.424791Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.428605Z","title":"Junaid, and W","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":83,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.428605Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:8d7a2e9659282ee2f9c1fd0df117bf5a341a653257dd29e972031ae359032b8a","observation_id":"5cfb421c-5cf3-466a-809f-80e6971ed680","resolution":{"observed_at":"2026-08-06T20:14:36.428605Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.431641Z","title":"Sivula, and A","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":84,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.431641Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:b246ffcfddad6142b224967051a2576fc9fbbc9a135dfea15fdb49af8e6b956c","observation_id":"35fd26cb-2e06-4cc0-b3a0-cb2ccc9fe13c","resolution":{"observed_at":"2026-08-06T20:14:36.431641Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.436205Z","title":"Nam, and S","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":85,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.436205Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:a07e7419444b28e80bae80f6ed24dfc308f1e65ae26f7c8c01d5de610e7af5be","observation_id":"2696b7d0-34dd-48b3-b6a7-e12249a01964","resolution":{"observed_at":"2026-08-06T20:14:36.436205Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.439222Z","title":"Nature Protocols, 2022","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":86,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.439222Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:a891e049e179d9ff3d2895bba631c48348e06471e825b5d38fc9e469001c82d1","observation_id":"13ef8a4a-f18e-413c-974f-68b449d7b833","resolution":{"observed_at":"2026-08-06T20:14:36.439222Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.442456Z","title":"Nature Computational Science, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":87,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.442456Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:e58e8c99c5bd5740bc2e5bf9b40786d4c84410b3e5bdb17e503b101db7e3654b","observation_id":"6b76caa7-17a4-4ad8-992e-511bc2ee11dd","resolution":{"observed_at":"2026-08-06T20:14:36.442456Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2503.20913","last_updated":"2025-03-26T18:35:34Z","snapshot_observed_at":"2026-08-07T16:34:39.043419Z","submitted_at":"2025-03-26T18:35:34Z","title":"TransDiffSBDD: Causality-Aware Multi-Modal Structure-Based Drug Design","version":1},"cited_work":{"arxiv_id":"2503.20913","doi":null,"metadata_source":"pith","pith_arxiv_id":"2503.20913","snapshot_observed_at":"2026-08-06T20:14:37.184087Z","title":"TransDiffSBDD: Causality-Aware Multi-Modal Structure-Based Drug Design","venue":"cs.CE","work_id":"e4f5e18f-1b6c-48a5-943b-4d254cf89a01","year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":88,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.445381Z"},"links":{"cited_paper":"/paper/2503.20913","citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:29f91abe92ed983765a3177736f05e1199194f23a05c49f1c406bee54beb99c4","observation_id":"4fa4719d-535a-4e18-8287-0596a9df2ada","resolution":{"observed_at":"2026-08-06T20:14:37.190294Z","resolver_source":"local_arxiv","status":"metadata_mismatch"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-08T06:32:00.761636+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-08T06:32:00.761636+00:00","source":"crossref"},{"observed_at":"2026-08-08T06:31:55.24221+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.448500Z","title":"Biomarker Research, 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":89,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.448500Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:077e134ba7cabfd1e5783ee3fd01465b137eb8236e4e7fba5a56a28ce040d939","observation_id":"3f4321a4-6067-4a58-80cd-e192cc00bde5","resolution":{"observed_at":"2026-08-06T20:14:36.448500Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.452280Z","title":"Virtual screening: principles, challenges, and practical guidelines, 2011: p","venue":null,"work_id":null,"year":2011},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":90,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.452280Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:2dc857d8a64939ce0a3c472a22b46e3aad7ede2e1c8f33183a0ceb3bf89d716b","observation_id":"910152ae-ddd8-4a56-81bb-8ebd7d9549af","resolution":{"observed_at":"2026-08-06T20:14:36.452280Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.455386Z","title":"Nisius, and J","venue":null,"work_id":null,"year":2011},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":91,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.455386Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:42e73d6d17fef0ab38c539edb2be0d467661fcf9cadcf1fc8e2c5c33d60a9eb9","observation_id":"242b6450-3242-4402-b72c-eaf80a4f19dc","resolution":{"observed_at":"2026-08-06T20:14:36.455386Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.459425Z","title":"Scientific Reports, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":92,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.459425Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:628a6b2f5d8e979da80d1557b2eae268d59b0697c90dc85d794c16658d430328","observation_id":"4b752d37-86b0-4fef-a99d-f83558bbc513","resolution":{"observed_at":"2026-08-06T20:14:36.459425Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.462442Z","title":"ACS omega, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":93,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.462442Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:e5860fcd38776a55d8844807c92cf95d2992c06af0d2a737222808d45eea24fc","observation_id":"19753efb-fcb7-4f97-908c-c6c038f18d62","resolution":{"observed_at":"2026-08-06T20:14:36.462442Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.465983Z","title":null,"venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":94,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.465983Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:38e29ab4687f90d628ecfeafdd77cd40da57ab120bb9adee29957a7f3ebf3400","observation_id":"df3ecbc4-fe62-4038-a40f-e8ad40fd5085","resolution":{"observed_at":"2026-08-06T20:14:36.465983Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.469407Z","title":"Science of The Total Environment, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":95,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.469407Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:391712fb5e5b8a3cd8df501c99048afb01df64b9c5da9ccd6e3a649709ca000a","observation_id":"37bbf6a0-b205-4e1a-994d-55377e8a797a","resolution":{"observed_at":"2026-08-06T20:14:36.469407Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.472497Z","title":"ACS omega, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":96,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.472497Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:47ed85d07e935fbfb33018ea8316855940799cd3741a5c5be8561cc6793b0365","observation_id":"2c9e0c8e-4509-4445-b09f-1db2ff26b5e0","resolution":{"observed_at":"2026-08-06T20:14:36.472497Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.475369Z","title":"Journal of Chemical Information and Modeling, 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":97,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.475369Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:ed0a22d605bd22519e53b55bd116cf2fca7072f11c723ba44755e936dcf8b2f9","observation_id":"b131fcf5-1eae-4674-8c16-a24b04c8e4cf","resolution":{"observed_at":"2026-08-06T20:14:36.475369Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.478583Z","title":null,"venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":98,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.478583Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:2c9efbb6503cb79553afe425d83085aa35eafecca1b95270430a4b29d0665ae2","observation_id":"2bbbb2c6-4d24-4408-8610-2bfd4671b879","resolution":{"observed_at":"2026-08-06T20:14:36.478583Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.481429Z","title":null,"venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":99,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.481429Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:ed32dd50808be482c4a51ea2b1a3290f708de743c711acfc808ed6ca30169198","observation_id":"67c69ea1-4388-4130-b2f4-e6fee693f4d3","resolution":{"observed_at":"2026-08-06T20:14:36.481429Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.484419Z","title":"Journal of Chemical Information and Modeling,","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":100,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.484419Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:7efc52f48bf53488eabcee8c5601d9ab1fd97f4e14c4593248a19bf11ae96c40","observation_id":"224a1cfd-3094-4f61-a630-f65367cbb020","resolution":{"observed_at":"2026-08-06T20:14:36.484419Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}}],"paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","latest_version":1,"primary_category":"cs.AI","snapshot_observed_at":"2026-08-06T20:08:49.646405Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy"},"reference_resolution":{"displayed":100,"state_counts":{"malformed_identifier":0,"metadata_mismatch":2,"parse_uncertain":0,"unresolved":98,"verified_exact":0,"verified_fuzzy":0},"total_outbound_references":300},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-08T06:32:00.761636+00:00","source":"crossref"},{"observed_at":"2026-08-08T06:31:55.24221+00:00","source":"retraction_watch"}],"thesis":"As of 8 August 2026, this Paper Citation Record lists 100 of 300 outbound references and 0 inbound Pith citation observations for arXiv:2507.03407."}